104347-84-4

Basic information

• Product Name: BOC-L-CYCLOPROPYL-ALA-OH METHYL ESTER
• Synonyms: BOC-L-CYCLOPROPYL-ALA-OH METHYL ESTER
• CAS NO: 104347-84-4
• Molecular Formula: C₁₂H₂₁NO₄
• Molecular Weight: 243.301
• Mol File: 104347-84-4.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: BOC-L-CYCLOPROPYL-ALA-OH METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-L-CYCLOPROPYL-ALA-OH METHYL ESTER(104347-84-4)
• EPA Substance Registry System: BOC-L-CYCLOPROPYL-ALA-OH METHYL ESTER(104347-84-4)

Safety Data

• Hazardous Substances Data: 104347-84-4(Hazardous Substances Data)

Upstream product

• 89483-06-7 (2S)-2-[[(tert-butoxy)carbonyl]amino]-3-cyclopropylpropanoic acid 
• 74-88-4 methyl iodide 
• 732231-41-3 methyl (S)-2-amino-3-cyclopropylpropanoate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 102735-53-5 (2S)-2-amino-3-cyclopropylpropanoic acid 

Downstream Products

• 89483-06-7 (2S)-2-[[(tert-butoxy)carbonyl]amino]-3-cyclopropylpropanoic acid 

Relevant articles and documents

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

NOVEL PYRAZINE DERIVATIVES

The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament. In particular, the compound may be used as a preferential agonist of Cannabinoid Receptor 2.

NOVEL PYRIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.